Fresh frozen plasma (FFP) transfusion in the intensive care unit (ICU) is commonly used to treat coagulopathy and bleeding in cardiac surgery, despite suggestion that it may increase the risk of morbidity and mortality through mechanisms such as fluid overload and infection.
Methods
We retrospectively studied consecutive adults undergoing cardiac surgery from the Medical Information Mart for Intensive Care III and IV databases. We applied propensity score matching to investigate the independent association of within-ICU FFP transfusion with mortality and other key clinical outcomes.
Results
Of our 12,043 adults who met inclusion criteria, 1585 (13.2%) received perioperative FFP with a median of 2.48 units per recipient (interquartile range [IQR]: 2.04, 4.33) at a median time of 1.83 h (IQR: 0.75, 3.75) after ICU admission. After propensity matching of 952 FFP recipients to 952 controls, we found no significant association between FFP use and hospital mortality (odds ratio (OR): 1.58; 99% confidence interval (CI): 0.57, 3.71), suspected infection (OR: 0.72; 99% CI: 0.49, 1.08), or acute kidney injury (OR: 1.23; 99% CI: 0.91, 1.67). However, FFP was associated with increased days in hospital (adjusted mean difference (AMD): 1.28; 99% CI: 0.27, 2.41; p = .0050), days in intensive care (AMD: 1.28; 99% CI: 0.27, 2.28; p = .0011), and chest tube output in millilitres up to 8 h after transfusion (AMD: 92.98; 99% CI: 52.22, 133.74; p < .0001).
Conclusions
After propensity matching, FFP transfusion was not associated with increased hospital mortality, but was associated with increased length of stay and no decrease in bleeding in the early post-transfusion period.
HartmannMSuckerCBoehmO, et al.Effects of cardiac surgery on hemostasis. Transfus Med Rev2006; 20: 230–241.
2.
DesboroughMSanduRBrunskillSJ, et al.Fresh frozen plasma for cardiovascular surgery. Cochrane Database Syst Rev2015; 2015: CD007614. DOI: 10.1002/14651858.CD007614.pub2.
3.
RobackJDCaldwellSCarsonJ, et al.Evidence-based practice guidelines for plasma transfusion. Transfusion2010; 50: 1227–1239.
4.
RaphaelJMazerCDSubramaniS, et al.Society of cardiovascular anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients. J Cardiothorac Vasc Anesth2019; 33: 2887–2899.
5.
TibiPMcClureRSHuangJ, et al.STS/SCA/AmSECT/SABM update to the clinical practice guidelines on patient blood management. Ann Thorac Surg2021; 112: 981–1004.
6.
YangLStanworthSHopewellS, et al.Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials (CME). Transfusion2012; 52: 1673–1686.
7.
FerrarisVABrownJRDespotisGJ, et al.2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg2011; 91: 944–982. DOI: 10.1016/j.athoracsur.2010.11.078.
8.
HesselEA2ndLevyJH. Guidelines for perioperative blood transfusion and conservation in cardiac surgery: lessons and challenges. Anesth Analg2010; 111: 1555–1559. DOI: 10.1213/ANE.0b013e3181fbb386. 2010/11/26.
9.
PrathibaRJayaraneeSRameshJC, et al.An audit of fresh frozen plasma usage in a tertiary referral centre in a developing country. Malays J Pathol2001; 23: 41–46.
10.
American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American society of anesthesiologists task force on perioperative blood management. Anesthesiology2015; 122: 241–275. DOI: 10.1097/aln.0000000000000463.
11.
PaganoDMilojevicMMeestersMI, et al.2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. Eur J Cardio Thorac Surg2018; 53: 79–111.
12.
ShanderASGoodnoughLT. Blood transfusion as a quality indicator in cardiac surgery. JAMA2010; 304: 1610–1611. DOI: 10.1001/jama.2010.1483.
13.
HajjarLAVincentJLGalasFR, et al.Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA2010; 304: 1559–1567. DOI: 10.1001/jama.2010.1446.
14.
Bennett-GuerreroEZhaoYO’BrienSM, et al.Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA2010; 304: 1568–1575. DOI: 10.1001/jama.2010.1406.
15.
ShahAStanworthSMcKechnieS. Evidence and triggers for the transfusion of blood and blood products. Anaesthesia2015; 70 Suppl 1: 10–19.
16.
McQuiltenZKAndrianopoulosNWoodEM, et al.Transfusion practice varies widely in cardiac surgery: results from a national registry. J Thorac Cardiovasc Surg2014; 147: 1684–1690.
17.
MingYLiuJZhangF, et al.Transfusion of red blood cells, fresh frozen plasma, or platelets is associated with mortality and infection after cardiac surgery in a dose-dependent manner. Anesth Analg2020; 130: 488–497.
18.
SmithMMKorDJFrankRD, et al.Intraoperative plasma transfusion volumes and outcomes in cardiac surgery. J Cardiothorac Vasc Anesth2020; 34: 1446–1456.
19.
BjurstenHDardashtiAEderothP, et al.Increased long-term mortality with plasma transfusion after coronary artery bypass surgery. Intensive Care Med2013; 39: 437–444.
20.
GokalpOKestelliMYurekliI. Effect of the use of fresh frozen plasma in cardiac surgery on the postoperative serum creatinine values. Turkish J Thorac Cardiovasc Surg2011; 19: 490–494.
21.
TsukinagaAMaedaTTakakiS, et al.Relationship between fresh frozen plasma to packed red blood cell transfusion ratio and mortality in cardiovascular surgery. J Anesth2018; 32: 539–546.
22.
DoussauAPerezPPuntousM, et al.Fresh-frozen plasma transfusion did not reduce 30-day mortality in patients undergoing cardiopulmonary bypass cardiac surgery with excessive bleeding: the plasmacard multicenter cohort study. Transfusion2014; 54: 1114–1124.
23.
BiancoVAranda-MichelESerna-GallegosD, et al.Transfusion of non–red blood cell blood products does not reduce survival following cardiac surgery. J Thorac Cardiovasc Surg2022. In press. [23 February, 2022].
24.
GeisslerRGRoteringHBuddendickH, et al.Utilisation of blood components in cardiac surgery: a single-centre retrospective analysis with regard to diagnosis-related procedures. Transfus Med Hemotherapy2015; 42: 75–82. DOI: 10.1159/000377691.
25.
KleinAArnoldPBinghamR, et al.AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia2016; 71: 829–842.
26.
PybusSMacCormacAHoughtonA, et al.Inappropriateness of fresh frozen plasma for abnormal coagulation tests. J R Coll Physicians Edinb2012; 42: 294–300.
27.
HaasTFriesDTanakaK, et al.Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence?Br J Anaesth2015; 114: 217–224.
28.
HickeyGLGrantSWDunningJ, et al.Statistical primer: sample size and power calculations—why, when and how?Eur J Cardio Thorac Surg2018; 54: 4–9.
29.
IrvingAHHarrisAPetrieD, et al.Impact of patient blood management guidelines on blood transfusions and patient outcomes during cardiac surgery. J Thorac Cardiovasc Surg2020; 160: 437–445. DOI: 10.1016/j.jtcvs.2019.08.102.
30.
PearseBLKeoghSRickardCM, et al.Bleeding management practices of Australian cardiac surgeons, anesthesiologists and perfusionists: a cross-sectional national survey incorporating the theoretical domains framework (TDF) and com-B model. J Multidiscip Healthc2020; 13: 27–41. DOI: 10.2147/JMDH.S232888.
31.
BolligerDMauermannETanakaKA. Thresholds for perioperative administration of hemostatic blood components and coagulation factor concentrates: an unmet medical need. J Cardiothorac Vasc Anesth2015; 29: 768–776.
32.
von ElmEAltmanDGEggerM, et al.Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Br Med J2007; 335: 806–808. DOI: 10.1136/bmj.39335.541782.
33.
JohnsonAEPollardTJShenL, et al.MIMIC-III, a freely accessible critical care database. Sci Data2016; 3: 160035. DOI: 10.1038/sdata.2016.35.
34.
JohnsonAEBulgarelliLShenLGaylesAShammoutAHorngSPollardTJHaoSMoodyBGowBLehmanMIMIC-IVLW., a freely accessible electronic health record dataset. Scientific data. 2023Jan 3;10(1):1.
35.
GoldbergerALAmaralLAGlassL, et al.PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation2000; 101: E215–E220. DOI: 10.1161/01.cir.101.23.e215.
36.
NascimentoBCallumJRubenfeldG, et al.Clinical review: fresh frozen plasma in massive bleedings-more questions than answers. Crit Care2010; 14: 202–208.
37.
RaithEPUdyAABaileyM, et al.Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA2017; 317: 290–300.
38.
Shankar-HariMPhillipsGSLevyML, et al.Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA2016; 315: 775–787.
39.
The Royal Children’s Hospital Melbourne. Blood product prescription. Parkville, VIC: The Royal Children’s Hospital Melbourne, 2018.
40.
BuurenSGroothuis-OudshoornK. Mice: multivariate imputation by chained equations in R. J Stat Software2011; 45: 67. DOI: 10.18637/jss.v045.i03.
41.
AustinPC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharmaceut Stat2011; 10: 150–161.
42.
AustinPC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res2011; 46: 399–424.
43.
PishgarFGreiferNLeyratC, et al.MatchThem: matching and weighting after multiple imputation. The R Journ2021; 13: 228–305.
44.
VanderWeeleTJDingP. Sensitivity analysis in observational research: introducing the e-value. Ann Intern Med2017; 167: 268–274. DOI: 10.7326/M16-2607.
45.
RosnerGFKirtaneAJGenereuxP, et al.Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Circulation2012; 125: 2613–2620.
46.
JakobsenC-JRyhammerPKTangM, et al.Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients. Eur J Cardio Thorac Surg2012; 42: 114–120.
47.
BanburyMKBrizzioMERajeswaranJ, et al.Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg2006; 202: 131–138.
48.
FletcherCMHintonJVXingZ, et al.Platelet transfusion after cardiac surgery. J Cardiothorac Vasc Anesth2023; 37: 528–538.
49.
HintonJVXingZFletcherCM, et al.Cryoprecipitate transfusion after cardiac surgery. Heart Lung Circ2022; 32(3): 414–423.
50.
NaghipourBAhmadiSFaridaalaeeG, et al.FFP transfusion and nosocomial infection in cardiac surgery: a systematic review. Intern Cardiovas Res J2019; 13: 109–114.
51.
SreeramGMWelsbyIJSharmaAD, et al.Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions. J Cardiothorac Vasc Anesth2005; 19: 430–434.
52.
KindzelskiBACorcoranPSiegenthalerMP, et al.Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery. Perfusion2018; 33: 62–70. DOI: 10.1177/0267659117712405.
53.
ParreirasVCRochaISMartinsAS, et al.Influence of fresh frozen plasma as a trigger factor for kidney dysfunction in cardiovascular surgery. Rev Bras Cir Cardiovasc2012; 27: 405–410. DOI: 10.5935/1678-9741.20120069.
54.
RasmussenSRKandlerKNielsenRV, et al.Association between transfusion of blood products and acute kidney injury following cardiac surgery. Acta Anaesthesiol Scand2020; 64: 1397–1404.
55.
AzarfarinRAshouriNTotonchiZ, et al.Factors influencing prolonged ICU stay after open heart surgery. Res Cardiovasc Med2014; 3: e20159. DOI: 10.5812/cardiovascmed.20159.
56.
DykeCAronsonSDietrichW, et al.Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg2014; 147: 1458–1463. DOI: 10.1016/j.jtcvs.2013.10.070.
57.
DixonBSantamariaJDReidD, et al.The association of blood transfusion with mortality after cardiac surgery: cause or confounding? (CME). Transfusion2013; 53: 19–27.
58.
GörlingerKFriesDDirkmannD, et al.Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemotherapy2012; 39: 104–113.
59.
KorDJStubbsJRGajicO. Perioperative coagulation management–fresh frozen plasma. Best Pract Res Clin Anaesthesiol2010; 24: 51–64.
60.
OrtmannEBesserMWSharplesLD, et al.An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth Analg2015; 121: 26–33.
61.
ErdoesGKosterAMeestersM, et al.The role of fibrinogen and fibrinogen concentrate in cardiac surgery: an international consensus statement from the haemostasis and transfusion scientific subcommittee of the European association of cardiothoracic anaesthesiology. Anaesthesia2019; 74: 1589–1600.
62.
MüllerMCArbousMSSpoelstra-de ManAM, et al.Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion2015; 55: 26–35.
63.
DeppeA-CWeberCZimmermannJ, et al.Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients. J Surg Res2016; 203: 424–433.
64.
RanucciMPistuddiVBaryshnikovaE, et al.Fibrinogen levels after cardiac surgical procedures: association with postoperative bleeding, trigger values, and target values. Ann Thorac Surg2016; 102: 78–85.
65.
TheusingerOBauligWSeifertB, et al.Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. Br J Anaesth2011; 106: 505–511.
66.
Kozek-LangeneckerSSørensenBHessJR, et al.Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care2011; 15: 1–25.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
